Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Actavis Group
Harvard Business School Publishes a Case Study on Robert Wessman and Actavis
May 9th, 2008
Actavis Group, the international generic pharmaceuticals company, announced that Harvard Business School has published a case study on the Company and its President and CEO. The study, entitled "Robert Wessman and Actavis' 'Winning formula'" was presented in an MBA class in international entrepreneurship at Harvard Business School. The case will be made available to business schools around the world. Dr. Daniel Isenberg, Senior lecturer of Business administration at Harvard Business School, expressed interest in creating a case study of how what started as a relatively small Icelandic pharmaceutical company has today gone on to become one of the most important players...
Source: Health Business Week (2008-05-09)
|
